Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic ImpactJCO GLOBAL ONCOLOGYIF32021-12-014OAAI
Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelinesRADIOTHERAPY AND ONCOLOGYIF5.32016-01-0110PREAI
An estimation of population-based survival benefit of first-line chemotherapy for urological cancerEUROPEAN JOURNAL OF CANCERIF7.12015-09-010PREAI
Estimation of an Optimal Chemotherapy Utilisation Rate for Cancer: Setting an Evidence-based Benchmark for Quality Cancer CareCLINICAL ONCOLOGYIF32015-02-018PREAI
Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012RADIOTHERAPY AND ONCOLOGYIF5.32014-07-01456PREAI
Estimation of the Optimal Brachytherapy Utilization Rate in the Treatment of Gynecological Cancers and Comparison With Patterns of CareINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52013-02-0112OAAI
A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of optimal therapyBREASTIF7.92012-08-019OAAI
A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of optimal therapyBREASTIF7.92012-08-0114OAAI
Chemotherapy in Rectal Cancer: Variation in Utilization and Development of an Evidence-based Benchmark Rate of Optimal Chemotherapy UtilizationCLINICAL COLORECTAL CANCERIF3.22011-06-016PREAI
Outcomes following a limited approach to radiotherapy in rectal cancerBRITISH JOURNAL OF SURGERYIF8.72011-06-0115OAAI
Estimation of an Optimal Chemotherapy Utilisation Rate for Primary Malignant Brain Tumours: an Evidence-based Benchmark for Cancer CareCLINICAL ONCOLOGYIF32011-02-013PREAI
Estimation of an optimal chemotherapy utilisation rate for breast cancer: Setting an evidence-based benchmark for the best-quality cancer careEUROPEAN JOURNAL OF CANCERIF7.12010-03-0115PREAI
Estimation of an Optimal Utilisation Rate for Palliative Radiotherapy in Newly Diagnosed Cancer PatientsCLINICAL ONCOLOGYIF32010-02-0124PREAI
Estimation of an optimal chemotherapy utilisation rate for colon cancer: An evidence-based benchmark for cancer careEUROPEAN JOURNAL OF CANCERIF7.12009-09-015PREAI
Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: Setting an evidence-based benchmark for the best-quality cancer careEUROPEAN JOURNAL OF CANCERIF7.12009-08-015PREAI
Estimation of optimal brachytherapy utilization rate in the treatment of malignancies of the uterine corpus by a review of clinical practice guidelines and the primary evidenceINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52008-11-015PREAI
Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma of the uterine cervix - Review of clinical practice guidelines and primary evidenceCANCERIF5.12006-12-0820OAAI
Estimating the Optimal Radiotherapy Utilization Rate Based on Clinical Guidelines and Best Available Evidence and Comparing it to Current PracticeRADIOTHERAPY AND ONCOLOGYIF5.32006-09-010PREAI
Estimating the optimal radiotherapy utilization for carcinoma of the central nervous system, thyroid carcinoma, and carcinoma of unknown primary origin from evidence-based clinical guidelinesCANCERIF5.12005-12-1415OAAI
The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelinesCANCERIF5.12005-08-031.5KOAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向